For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much ...
Apr 16, 2018
0
1007
Your immune system never sleeps. Every moment of the day, immune cells monitor your body for disease, calling for backup when they detect a threat. It's a system that works elegantly—most of the time. It's not foolproof; ...
Apr 5, 2018
0
34
Receptivity to advertising for e-cigarettes, cigarettes and cigars were confirmed to be associated with those who would try the respective tobacco product within one year. However, receptivity to e-cigarette advertising also ...
Mar 26, 2018
0
3
Childhood cancer is highly curable and, through collaboration, effective treatment is possible even in a crisis, according to an analysis from St. Jude Children's Research Hospital and the Children's Cancer Center of Lebanon ...
Feb 28, 2018
0
1
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is one of four cancer centers involved in testing a new "nanomedicine" ...
Jan 9, 2018
0
299
(HealthDay)—Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Dec 6, 2017
0
1
Patients at high risk for familial cancer, history of cancer at a young age, or history of multiple cancer occurrences may be referred to genetic counseling for genetic testing from the primary care office, which makes internists ...
Oct 30, 2017
0
57
Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment ...
Oct 26, 2017
0
5
A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with ...
Oct 25, 2017
0
0
EGFR is a common genetic target in lung cancer, but not all EGFR mutations are created equal. Patients with a type of EGFR anomaly called an "EGFR exon 20 insertion" often fail to respond to existing drugs targeting EGFR. ...
Oct 24, 2017
0
4
